CoVaccine HT? Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization.

Haun BK, Lai CY, Williams CA, Wong TAS, Lieberman MM, Pessaint L, Andersen H, Lehrer AT. CoVaccine HT? Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. Front Immunol. 2020; 11:599587.

View in: PubMed

subject areas

Adjuvants, Immunologic
Aluminum Hydroxide
Animals
Antibodies, Viral
Female
Humans
Immunity, Cellular
Immunity, Humoral
Immunization
Immunoglobulin G
Male
Mice
Mice, Inbred BALB C
Vaccines, Synthetic

authors with profiles

Axel Lehrer, PhD
Brien Haun, Ph.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support